電力藥學的全球市場
市場調查報告書
商品編碼
1099257

電力藥學的全球市場

Electroceuticals: Technologies and Global Markets

出版日期: | 出版商: BCC Research | 英文 117 Pages | 訂單完成後即時交付

價格

全球電力藥學的市場規模,2022年末有望達255億美元。

該市場,預計2022年~2027年的預測期間內以6.8%的年複合成長率擴大,2027年達到355億美元。

本報告提供全球電力藥學市場相關調查,市場概要,以及各產品,各終端用戶業界,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 簡介

第2章 摘要整理

第3章 概要

  • 簡介
  • 神經刺激
  • 心臟心臟去顫器及心臟心律調節器
  • 公共用心臟去顫器
  • 植入式心臟去顫器用的電池技術
  • 法律規範
  • 美國
  • EU
  • 日本

第4章 市場動態

第5章 COVID-19大流行的影響

第6章 全球電力藥學市場,各產品

  • 心臟心臟去顫器及心臟心律調節器
  • 神經刺激
  • 脊髓刺激
  • 腦深部刺激療法
  • 迷走神經刺激
  • 薦椎神經刺激
  • 經皮電刺激
  • 其他的刺激器
  • 助聽器和植入

第7章 全球電力藥學市場,各終端用戶

  • 醫院、診所
  • 居家醫療以及其他

第8章 全球電力藥學市場,各地區

  • 北美
  • 美國
  • 歐洲
  • 亞太地區
  • 日本
  • 中國
  • 印度
  • 其他地區

第9章 專利檢討

第10章 競爭情形

第11章 企業簡介

  • ABBOTT LABORATORIES
  • AXONICS MODULATION TECHNOLOGIES INC.
  • BIOVENTUS LLC
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORP.
  • COCHLEAR AMERICAS
  • COOK MEDICAL
  • EDWARDS LIFESCIENCES CORP.
  • GLAXOSMITHKLINE PLC
  • LEPU MEDICAL TECHNOLOGY(BEIJING)CO. LTD.
  • LIVANOVA PLC
  • MEDICO S.P.A.
  • MEDTRONIC PLC
  • MICROPORT SCIENTIFIC CORP.
  • STRYKER CORP.
  • ZOLL MEDICAL CORP.

第12章 附錄:縮寫

Product Code: MDS001B

Highlights:

The global electroceuticals market should reach $25.5 billion by the end of year 2022 and should reach more than $35.5 billion by year 2027, with a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2022-2027.

The cardioverter defibrillators and cardiac pacemaker product of the global electroceuticals market should reach $12.9 billion by the end of year 2022 and should reach more than $17.7 billion by year 2027 with a CAGR of 6.4% during the forecast period of 2022-2027.

The deep brain stimulation product of the global electroceuticals market should reach $1.2 billion by the end of year 2022 and should reach more than $2.2 billion by year 2027 with a CAGR of 11.5% during the forecast period of 2022-2027.

Report Scope:

This report highlights the current and future market potential for electroceuticals. It provides a detailed analysis of the competitive environment, regulatory scenario, and the drivers, restraints, opportunities, and trends in the market. The report also offers market projections through 2027.

This report covers the overall electroceuticals market, including cardiac pacemakers, implantable cardiac defibrillators, hearing aids and implants, and neurostimulation devices. The report also analyzes various end users of electroceuticals.

For this report, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (RoW), which includes Latin America, the Middle East and Africa). Major countries, including the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are analyzed. Market data was provided for 2020, which served as the base year, and forecasts are estimated through 2027. Estimated values are based on product manufacturers' total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

  • 19 data tables and 24 additional tables
  • An overview of global markets and technologies for electroceuticals
  • Analyses of global market trends, with data from 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Discussion on how electroceuticals are used as an alternative to drug-based remedies and analyses of endogenous and exogenous factors that are impacting the global market growth
  • Coverage of several diseases such as epilepsy, cardiovascular diseases, rheumatoid arthritis and diabetes and their treatment using electroceuticals
  • Information on RecoveryRx medical device, which is used for the treatment of postoperative pain of opioid/NSAID therapy
  • Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
  • Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size, and forecast
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
  • Company profiles of major players Abbott Laboratories, Boston Scientific, GlaxoSmithKline plc, Medtronic plc, Edwards Lifesciences Corp.

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing this Study
  • What's New in this Update?
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Executive Summary

Chapter 3 Overview

  • Introduction
  • Neurostimulation
  • Cardioverter Defibrillators and Cardiac Pacemakers
  • Public Access Defibrillators
  • Battery Technology for Implantable Cardiac Defibrillators
  • Regulatory Framework
  • United States
  • European Union
  • Japan

Chapter 4 Market Dynamics

  • Market Drivers
  • Increasing Incidence of CVD, Neurology and ENT Disorders
  • Aging Population
  • Increasing Healthcare Expenditures
  • Focus on Non-drug Therapies and Reducing Opioid Usage
  • Technology Innovations and New Product Developments
  • Market Restraints and Challenges
  • High Cost of Neurostimulation Procedures/Devices and Lack of Trained Healthcare Professionals
  • Inconsistent Reimbursement Policies

Chapter 5 Impact of COVID-19 Pandemic

  • Introduction
  • Impact on Neurostimulation Market
  • Impact on Market for ENT Devices

Chapter 6 Global Market for Electroceuticals by Product

  • Cardioverter Defibrillators and Cardiac Pacemakers
  • Neurostimulation
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Vagus Nerve Stimulation
  • Sacral Nerve Stimulation
  • Transcutaneous Electrical Nerve Stimulation
  • Other Stimulators
  • Hearing Aids and Implants
  • Hearing Aid Devices
  • Behind the Ear
  • Completely in the Canal
  • In the Ear
  • Hearing Implants
  • Cochlear Implants
  • Bone Anchored Hearing Implants
  • Middle Ear Implants

Chapter 7 Global Market for Electroceuticals by End User

  • Hospitals and Clinics
  • Homecare and Others

Chapter 8 Global Market for Electroceuticals by Region

  • North America
  • U.S.
  • Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of the World

Chapter 9 Patent Review

  • Introduction
  • Patents on Hearing Aids and Implants
  • Neurostimulation
  • Cardiac

Chapter 10 Competitive Landscape

  • Leading Companies in the Market for Neurostimulation Products
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Market for Hearing Aids and Implants by Company
  • Key Developments

Chapter 11 Company Profiles

  • ABBOTT LABORATORIES
  • AXONICS MODULATION TECHNOLOGIES INC.
  • BIOVENTUS LLC
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORP.
  • COCHLEAR AMERICAS
  • COOK MEDICAL
  • EDWARDS LIFESCIENCES CORP.
  • GLAXOSMITHKLINE PLC
  • LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD.
  • LIVANOVA PLC
  • MEDICO S.P.A.
  • MEDTRONIC PLC
  • MICROPORT SCIENTIFIC CORP.
  • STRYKER CORP.
  • ZOLL MEDICAL CORP.

Chapter 12 Appendix: Acronyms

List of Tables

  • Summary Table A : Global Market for Electroceuticals, by Product, Through 2027
  • Table 1 : Regulatory Approval: U.S. vs. Europe
  • Table 2 : U.S. FDA Product Classification: Defibrillators
  • Table 3 : U.S. FDA Pacemaker Product Classification
  • Table 4 : U.S. FDA Neurostimulator Product Classification, 2019
  • Table 5 : U.S. FDA Cochlear Implant Product Classification
  • Table 6 : Global Incidence of All Stroke Types, 2019
  • Table 7 : Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
  • Table 8 : Number of Disability-adjusted Life Years (DALYs)for Neurological Disorders and Share of Global DALYs Projected for 2005 and 2030
  • Table 9 : Deaths Attributable to Neurological Disorders, 2005 and 2030
  • Table 10 : World Population, Age 60 and Older, 2000-2050
  • Table 11 : Global Market for Electroceuticals, by Product, 2020-2027
  • Table 12 : Global Market for Cardioverter Defibrillators and Cardiac Pacemakers, by Region, Through 2027
  • Table 13 : Global Market for Spinal Cord Stimulators, by Region, Through 2027
  • Table 14 : Global Market for Deep Brain Stimulators, by Region, Through 2027
  • Table 15 : Global Market for Vagus Nerve Stimulators, by Region, Through 2027
  • Table 16 : Global Market for Other Stimulators, by Region, Through 2027
  • Table 17 : Global Market for Hearing Aids and Implants, by Region, Through 2027
  • Table 18 : Global Market for Electroceuticals, by End User, 2020-2027
  • Table 19 : Global Market for Hospitals and Clinics, by Region, Through 2027
  • Table 20 : Hospitals with Notable Services
  • Table 21 : Global Market for Homecare and Others, by Region, Through 2027
  • Table 22 : Global Market for Electroceuticals, by Region, 2020-2027
  • Table 23 : North American Market for Electroceuticals, by Country, Through 2027
  • Table 24 : Funding by Federal Government for Treatment of Chronic Diseases
  • Table 25 : European Market for Electroceuticals, by Country, Through 2027
  • Table 26 : Asia-Pacific Market for Electroceuticals, by Country, Through 2027
  • Table 27 : China's Medical Device Regulations
  • Table 28 : Out-of-Pocket Health Expenditures in Argentina, 2015-2019
  • Table 29 : Analysis of Patents Related to Electroceuticals
  • Table 30 : Number of Patents Related to Neurostimulation, by Patent Holder, January 2020 to May 2022
  • Table 31 : Number of Patents Related to Cardiac Stimulation, by Patent Holder, January 2020 to May 2022
  • Table 32 : Global Market Shares of Spinal Cord Stimulation Devices, by Company, 2020
  • Table 33 : Global Market Shares of Deep Brain Stimulation Devices, by Company, 2020
  • Table 34 : Abbott: Product Portfolio
  • Table 35 : Bioness: Product Information
  • Table 36 : Product Portfolio
  • Table 37 : Medico S.p.A.: Main Products
  • Table 38 : Medico S.p.A.: Recent Developments
  • Table 39 : Medtronic: Product Portfolio
  • Table 40 : MicroPort Scientific Corp.: Product Portfolio
  • Table 41 : Zoll Medical Corp.: Product Portfolio
  • Table 42 : Acronyms Used in This Report

List of Figures

  • Summary Figure A : Global Market for Electroceuticals, 2020-2027
  • Figure 1 : Global Deaths from CVD, 2015 and 2030
  • Figure 2 : Global Prevalence of Congestive Heart Failure and Stroke, 2004-2030
  • Figure 3 : Global Market for Electroceuticals, by Product, 2020-2027
  • Figure 4 : Pacemakers
  • Figure 5 : Global Market for Electroceuticals, by End User, 2020-2027
  • Figure 6 : Number of Hospitals in the U.S., by Type, 2020
  • Figure 7 : Healthcare Expenditures in the U.S., 2015 and 2025
  • Figure 8 : Trends in Healthcare Spending, by Institution, 2015-2040
  • Figure 9 : North American Market Shares of Electroceuticals, by Country, 2021
  • Figure 10 : European Market Shares of Electroceuticals, by Country, 2021
  • Figure 11 : Asia-Pacific Market Shares of Electroceuticals, by Country, 2021
  • Figure 12 : Out-of-Pocket Health Expenditures in Argentina, 2015-2019
  • Figure 13 : Percentage of Patents on Hearing Aids and Implants, by Country, January 2020 to May 2022
  • Figure 14 : Percentage of Patents on Hearing Aids and Implants, by Patent Holder, January 2020 to May 2022
  • Figure 15 : Percentage of Patents Related to Neurostimulation, by Country, January 2020 to May 2022
  • Figure 16 : Global Market Shares of Spinal Cord Stimulation Devices, by Company, 2020
  • Figure 17 : Global Market Shares of Deep Brain Stimulation Devices, by Company, 2020
  • Figure 18 : Global Market Shares of Hearing Aids and Implants, by Company, 2020
  • Figure 19 : Global Market Shares of Hearing Aids and Implants, by Company, 2020
  • Figure 20 : Abbott: Annual Revenue, 2018-2021
  • Figure 21 : Abbott: Vascular Business Annual Revenue, 2018-2021
  • Figure 22 : Abbott: Revenue Share, by Country, 2021
  • Figure 23 : Boston Scientific: Annual Revenue, 2018-2021
  • Figure 24 : Boston Scientific: Revenue Share, by Business, 2021
  • Figure 25 : Boston Scientific: Revenue Share, by Region, 2021
  • Figure 26 : GlaxoSmithKline plc: Annual Revenue, 2018-2020
  • Figure 27 : GlaxoSmithKline plc: Revenue Share, by Business Segment, 2020
  • Figure 28 : Medtronic: Annual Revenue, 2018-2021
  • Figure 29 : Medtronic Coronary & Peripheral Vascular Segment: Annual Revenue, 2019-2021
  • Figure 30 : Medtronic: Revenue Share, by Region, 2021